🇺🇸 FDA
Patent

US 6693130

Inhibitors of epoxide hydrolases for the treatment of hypertension

expired A61KA61K31/00A61K31/325

Quick answer

US patent 6693130 (Inhibitors of epoxide hydrolases for the treatment of hypertension) held by The Regents of the University of California expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/00, A61K31/325, A61K31/336, A61P